Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MiR-30e-5p is sponged by Kcnq1ot1 and represses Angiotensin II-induced hypertrophic phenotypes in cardiomyocytes by targeting ADAM9.

Experimental cell research - 15 Sept 2020

Wang Weiwei, Wu Chunwei, Ren Lina, Bao Yandong, Han Yuechi, Li Chen, Li Yuze

Abstract excerpt

Prolonged cardiac hypertrophy, a pathological compensatory response of the heart, finally leads to heart failure. Numerous studies have illustrated the vital roles of non-coding RNAs (ncRNAs) in cardiac hypertrophy. Here, we probed into the role and probable mechanism of microRNA-30e-5p (miR-30e-5p) in Angiotensin II (Ang-II)-stimulated hypertrophic cardiomyocytes. Intriguingly, the expression of hypertrophic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ADAM Proteins
Share to Angiotensin II

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Animals, Newborn

Share to Cardiomegaly

Share to Down-Regulation

Share to Myocytes, Cardiac

Share to RNA, Long Noncoding

Share to Up-Regulation

Source

Identifiers

PMID: 32535037
DOI: 10.1016/j.yexcr.2020.112140

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MiR-30e-5p is sponged by Kcnq1ot1 and represses Angiotensin II-induced hypertrophic phenotypes in cardiomyocytes by targeting ADAM9.PMID 32535037Read ↗

MiR‐26a‐5p alleviates cardiac hypertrophy and dysfunction via targeting ADAM17Semantic proximity Read ↗

Extracellular vesicular microRNAs and cardiac hypertrophySemantic proximity Read ↗

Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4Semantic proximity Read ↗

Heart-enriched long noncoding RNA NPPA-AS1 regulates pathological cardiac hypertrophy by initiating a EP300-GATA4 axisSemantic proximity Read ↗

Global Profile of tRNA-Derived Small RNAs in Pathological Cardiac Hypertrophy Plasma and Identification of tRF-21-NB8PLML3E as a New Hypertrophy SuppressorSemantic proximity Read ↗

Global Profile of tRNA-Derived Small RNAs in Pathological Cardiac Hypertrophy Plasma and Identification of tRF-21-NB8PLML3E as a New Hypertrophy MarkerSemantic proximity Read ↗

MicroRNA363-5p Targets Thrombospondin3 to Regulate Pathological Cardiac RemodelingSemantic proximity Read ↗

The microRNA in ventricular remodeling: the miR-30 familySemantic proximity Read ↗

Cardiomyocytes Deficiency of SENP1 Promotes Myocardial Fibrosis via Paracrine ActionSemantic proximity Read ↗

Expression Profile of microRNAs in Hypertrophic Cardiomyopathy and Effects of microRNA-20 in Inducing Cardiomyocyte Hypertrophy Through Regulating Gene MFN2Semantic proximity Read ↗

MicroRNA-129-5p targets keap-1 to protect against cardiomyocyte hypertrophy via Nrf2 pathwaySemantic proximity Read ↗

MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5ASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.